Wexma

What Wexma does

Wexma is a privately held Finnish digital healthcare company founded in 2011 and headquartered in Helsinki. The company builds patient symptom follow-up and self-management solutions for hospitals, clinics, healthcare organizations, and medical insurance companies, combining mobile applications (iOS, Android, and historically Windows Phone) with sensors, smart wearables, and cloud-based data management and analytics. Its flagship product is the Wexma Pain Diary, a pain management mobile service deployed at three hospitals of Helsinki University Hospital (HUS) since summer 2015, which achieved patient satisfaction of 4.1/5, clinician satisfaction of 4.0/5, and 100% stated willingness to adopt in a published user satisfaction survey.

The company's technology stack centers on user-friendly mobile applications integrated with real-time sensory data and cloud analytics, positioned as a digital innovation partner to accelerate healthcare organizations' digital transformation. The solutions target both special and primary healthcare and are designed to improve patient-doctor communication, support clinical decision-making, enable timely interventions, and reduce treatment costs through improved self-management. Wexma operates under a subscription/recurring revenue model via direct enterprise sales to healthcare providers and partners.

Wexma is led by founding partners Pentti Paalu (sales) and Timo Simula (technology), both with prior corporate executive experience at Nokia, Elisa, and IBM. Capital has been raised from founders' own funds, the Finnish Innovation Centre TEKES, and Finnvera. The company's strategic relationships include Microsoft (via the AI in Health Partner Alliance from February 2017), HUS as a co-development customer, and Innofactor Plc as a resource partner. Wexma has received national recognition as a finalist in the Finnish Digital Health Kasvu Open growth competition (October 2016) and participated in the 5th EU Health Innovation event in Brussels (January 2016).

Name

Wexma

Legal name

Wexma

Website

https://wexma.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Wexma is a Finnish digital healthcare company that builds mobile-based patient symptom follow-up and self-management solutions — including the Wexma Pain Diary — combining apps, sensors, wearables, and cloud analytics for hospitals, clinics, and health insurers.

Ownership category

akta.pro rank

Product category

Digital Health Software

NAICS

Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Condition-specific Digital Therapeutics (DTx) (HLACANAA)

akta.pro secondary industries

DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO), SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)

Keywords

• Digital health solutions
• Symptom tracking software
• Pain management apps
• Healthcare analytics platform
• Patient monitoring solutions

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Healthcare Digital Solutions: Cost-effective digital services and solutions for health and social care organizations including mobile applications, sensor integration, and cloud-based analytics services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Wexma develops and licenses digital healthcare solutions focused on symptom management and decision support. The company offers mobile applications for patients to track pain and quality of life, integrated with sensor and wearable device data, and provides cloud-based analytics tools for healthcare providers to deliver evidence-based care.

Product overview

Wexma offers a unified suite of healthcare digital solutions centered around patient symptom follow-up and self-management. The core offering includes the Wexma Pain Diary mobile application (available on iPhone, Android, and Windows Phone) used for pain tracking, combined with mobile applications integrated with sensors and smart wearables, all connected to cloud-based data management and analytics services. These solutions are designed for hospitals, clinics, healthcare organizations, and medical insurance companies to improve patient-doctor communication, support clinical decision-making, and enable timely interventions.

Differentiator

Problem solved

Functional benefit

Products and services

• Wexma Pain Diary Mobile application that allows patients to track pain and quality of life over time, designed for self-management of chronic conditions and for use in clinical care pathways.
• Patient Symptom Follow-up Solutions Licensed digital solutions for hospitals and clinics to follow up on patient symptoms and quality of life, integrating mobile apps, sensors, and cloud analytics for evidence-based decision support.
• Wexma Mobile Applications Suite of mobile applications delivered as part of Wexma's healthcare platform, enabling patient self-management and structured symptom data capture.

Quantifiable outcome

• Patient satisfaction score of 4.1 out of 5 using iPhone, Android and Windows Phone
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• MicrosoftcoreTechnology or Integration · 17 February 2017Wexma joined the Microsoft AI in Health Partner Alliance, a group focused on advancing health technology. Wexma will receive access to Microsoft AI technologies for application to pain management solutions. The Alliance aims to drive public awareness of how AI can empower better clinical and operational outcomes.
• HUS (Helsinki University Hospital)coreStrategic or Co-development PartnerClose co-operation with HUS for healthcare solution development and deployment. Wexma's pain management service has been in use at three HUS hospitals since summer 2015, receiving excellent user satisfaction reviews.
• Innofactor PlcminorStrategic or Co-development PartnerNasdaq OMX Helsinki listed Company Innofactor Plc is a resource partner for Wexma, providing additional capabilities in the ecosystem.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Kaiku Health: Finnish-founded digital therapeutics platform for symptom tracking and patient-reported outcomes, originally in oncology. Closely comparable to Wexma as a Nordic DTx vendor offering patient symptom follow-up to hospitals, with cloud-based analytics integration.
• Kaia Health: Digital therapeutic focused on musculoskeletal pain management delivered via mobile app. Directly comparable to Wexma Pain Diary in target condition (pain), DTx delivery model, and enterprise payer/provider sales motion.
• Voluntis: Digital therapeutics company developing SaMD solutions that combine mobile apps with clinical decision support. Comparable to Wexma in software-as-a-medical-device positioning, mobile delivery, and hospital/payer sales channel.
• Noona (Varian Medical Systems): Originally a Finnish digital health company (now part of Varian) providing patient symptom management and communication tools for cancer care. Comparable as a Nordic-rooted symptom follow-up and patient engagement platform sold to hospital systems.

Broad incumbents

• Ada Health: Large-scale symptom assessment and digital health platform with broader consumer and enterprise reach. Comparable as a symptom/decision-support digital health vendor, though operating at significantly greater scale and geographic footprint.

Emerging players

• Oviva: European digital therapeutics provider delivering app-based behavior change and remote care programs reimbursed by payers. Comparable to Wexma in DTx model, mobile delivery, and European payer/provider sales.
• AppliedVR: Digital therapeutic company delivering evidence-based VR therapy for chronic pain. Comparable to Wexma Pain Diary in targeting chronic pain with a software-based therapeutic reimbursed through payer/provider channels.
• Sidekick Health: Nordic digital therapeutics company offering condition-specific DTx apps (including chronic pain and metabolic conditions) to insurers and providers. Comparable to Wexma in DTx delivery and Nordic enterprise sales motion, though broader in condition coverage.

Regional players

• Medixine: Finnish digital health platform offering mobile patient communication, remote monitoring, and analytics to healthcare providers. Comparable as a Finnish peer with overlapping hospital customers, symptom follow-up functionality, and cloud-based delivery.
• Wellmo: Finnish mobile health platform providing wellness and care apps integrated with wearables and sensors to insurers and healthcare providers. Comparable to Wexma in mobile-plus-sensor architecture and Finnish health buyer focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/WexmaHealthcare
• Facebookfacebook.com/WexmaHealthcare
• LinkedInlinkedin.com/company/wexma-oy

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wexma